Lab Information

Arielle Mendel (MD/MSc)

Junior Scientist
Centre for Outcomes Research and Evaluation
Department of Medicine (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 20%
 Epidemiology: 30%
 Evaluation: 50%
 This email address is being protected from spambots. You need JavaScript enabled to view it.


Systemic autoimmune rheumatic diseases • systemic vasculitis • systemic lupus erythematosus • patient safety and quality improvement • medication safety

Research Interests

My research focuses on patient safety in systemic autoimmune rheumatic disease. I aim to improve medication safety in this population by studying root causes of adverse drug events, with a particular focus on glucocorticoids (i.e., prednisone) and other immunosuppressive agents, in order to design innovative strategies for improving medication safety in this population.

Team Members

Name Position

Latest Publications

  1. Eder, L., Croxford, R., Drucker, A. M., Mendel, A., Kuriya, B., Touma, Z., Johnson, S. R., Cook, R., Bernatsky, S., Haroon, N. & Widdifield, J. (2022). COVID-19 hospitalizations, intensive care unit stays, ventilation and death among patients with immune mediated inflammatory diseases compared to controls. The Journal of rheumatology, vol. 49, p. 523-530.
  2. Barber, C. E. H., Levy, D. M., Ahluwalia, V., Mendel, A., Taylor-Gjevre, R., Gerschman, T., Koppikar, S., Jilkine, K., Stringer, E., Barnabe, C., Aydin, S. Z., Luca, N., Berard, R., Tam, K., Burt, J., Murdoch, J. C., Zinck, G., Lane, T., Heeley, J., Mannerow, M., Mills, R., Wilhelm, L., Spencer, N. & Ohata, B. (2022). Best Practices for Virtual Care, a Consensus Statement from the Canadian Rheumatology Association. The Journal of rheumatology, vol. 49, p. 408-418.
  3. Eder, L., Croxford, R., Drucker, A. M., Mendel, A., Kuriya, B., Touma, Z., Johnson, S. R., Cook, R., Bernatsky, S., Haroon, N. & Widdifield, J. (2021). Understanding COVID-19 Risk in Patients with Immune Mediated Inflammatory Diseases: A Population-based analysis of SARS-CoV-2 Testing. Arthritis care & research.
  4. Mendel, A. & Pagnoux, C. (2021). Use of Rituximab for the Treatment of Antineutrophil Cytoplasm Antibody-associated Vasculitis in Canada, 2010-2020. The Journal of rheumatology, vol. 48, p. 1755-1756.
  5. Mendel, A., Ennis, D., Lake, S., Carette, S. & Pagnoux, C. (2021). An Initiative to Improve Timely Glucocorticoid Tapering in Vasculitis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, vol. 27, p. e612-e615.
  6. Mendel, A., Ennis, D., Carette, S. & Pagnoux, C. (2020). Assessment of glucocorticoid tapering in large vessel and anti-neutrophil cytoplasmic antibody-associated vasculitides. Clinical and experimental rheumatology, vol. 39 Suppl 129, p. 119-124.
  7. Mendel, A., Ennis, D., Go, E., Bakowsky, V., Baldwin, C., Benseler, S. M., Cabral, D. A., Carette, S., Clements-Baker, M., Clifford, A. H., Cohen Tervaert, J. W., Cox, G., Dehghan, N., Dipchand, C., Dhindsa, N., Famorca, L., Fifi-Mah, A., Garner, S., Girard, L.-P., Lessard, C., Liang, P., Noone, D., Makhzoum, J.-P., Milman, N., Pineau, C. A., Reich, H. N., Rhéaume, M., Robinson, D. B., Rumsey, D. G., Towheed, T. E., Trudeau, J., Twilt, M., Yacyshyn, E., Yeung, R. S. M., Barra, L. B., Khalidi, N. & Pagnoux, C. (2021). CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update. The Journal of rheumatology, vol. 48, p. 555-566.
  8. Mendel, A., Bernatsky, S., Askanase, A., Bae, S.-C., Clarke, A. E., Costedoat-Chalumeau, N., Gladman, D. D., Gordon, C., Hanly, J., Jacobsen, S., Kalunian, K., Mak, A., Mosca, M., Pons-Estel, B. A., Ruiz-Irastorza, G., Urowitz, M. & Vinet, É. (2021). Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics. Annals of the rheumatic diseases, vol. 80, p. 1-2.
  9. Mendel, A., Bernatsky, S., Thorne, J. C., Lacaille, D., Johnson, S. R. & Vinet, É. (2020). Hydroxychloroquine shortages during the COVID-19 pandemic. Annals of the rheumatic diseases.
  10. Mendel, A., Bernatsky, S., Pineau, C. A., St-Pierre, Y., Hanly, J. G., Urowitz, M. B., Clarke, A. E., Romero-Diaz, J., Gordon, C., Bae, S.-C., Wallace, D. J., Merrill, J. T., Buyon, J., Isenberg, D. A., Rahman, A., Ginzler, E. M., Petri, M., Dooley, M. A., Fortin, P., Gladman, D. D., Steinsson, K., Ramsey-Goldman, R., Khamashta, M. A., Aranow, C., Mackay, M., Alarcón, G., Manzi, S., Nived, O., Jönsen, A., Zoma, A. A., van Vollenhoven, R. F., Ramos-Casals, M., Ruiz-Irastorza, G., Lim, S., Kalunian, K. C., Inanc, M., Kamen, D. L., Peschken, C. A., Jacobsen, S., Askanase, A., Sanchez-Guerrero, J., Bruce, I. N., Costedoat-Chalumeau, N. & Vinet, E. (2019). Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. Rheumatology (Oxford, England), vol. 58, p. 1259-1267.
More on PubMed 

See also

Card image

See profile
Card image

See profile
Card image

See profile